Makoto Sano

Years Active: 2022-2024
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Hiroyuki Kato, Motonori Sato, Aya Naiki-Ito, Shingo Inaguma, Makoto Sano, Masayuki Komura, Yuko Nagayasu, Kuang Xiaochen, Akihisa Kato, Yoichi Matsuo, Hideaki Ijichi, Satoru Takahashi
The role of DPYD and the effects of DPYD suppressor luteolin combined with 5-FU in pancreatic cancer. Cancer medicine 13 (16) (2024)
Hiroyuki Kato, Motonori Sato, Aya Naiki-Ito, Shingo Inaguma, Makoto Sano, Masayuki Komura, Yuko Nagayasu, Kuang Xiaochen, Akihisa Kato, Yoichi Matsuo, Hideaki Ijichi, Satoru Takahashi
The role of DPYD and the effects of DPYD suppressor luteolin combined with 5-FU in pancreatic cancer. Cancer medicine 13 (16) (2024)
Tomoaki Itaya, Makoto Sano, Ichie Kajiwara, Yukino Oshima, Tomoya Kuramochi, Jinsuk Kim, Yoshimi Ichimaru, Osamu Kitajima, Atsushi Masamune, Hideaki Ijichi, Yukimoto Ishii, Takahiro Suzuki
Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer. Pain (2022)
Tomoaki Itaya, Makoto Sano, Ichie Kajiwara, Yukino Oshima, Tomoya Kuramochi, Jinsuk Kim, Yoshimi Ichimaru, Osamu Kitajima, Atsushi Masamune, Hideaki Ijichi, Yukimoto Ishii, Takahiro Suzuki
Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer. Pain (2022)

Makoto Sano.css-eqlu8i{font-size:small;padding-left:4px;}